Patent · US Active

Heteroaryl compounds as IRAK inhibitors and uses thereof

US9790221B2 · kind B2 · utility

4Cited by

0References

17Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Catherine Jorand-Lebrun · Arlington, US
Reinaldo Jones · Lowell, US
Annie Cho Won · Groton, US
Ngan Nguyen · Arlington, US
Theresa L. Johnson · Salem, US
Lizbeth Celeste Deselm · Melrose, US
Kausik Panda · Savanuru, IN

Key dates

Filing date	Nov 19, 2015
Grant date	Oct 17, 2017
Priority date	—
Expiry date	Nov 19, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.